Fu-zheng-qu-zhuo Oral Liquid Improves Renal Function in Patients of CKD Stage 3 and 4

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 124 participants.

Also called NCT02275468

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 124 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02275468
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02275468. Randomized; double masking; primary purpose treatment. Start 2010-06 (registry gives no type); primary completion 2013-05 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Fu-zheng-qu-zhuo Oral Liquid Improves Renal Function in Patients of CKD Stage 3 and 4
Condition
Stage 3 Chronic Kidney Disease
Condition
Stage 4 Chronic Kidney Disease
Intervention (Drug)
Fu-zheng-qu-zhuo (FZQZ) oral liquid
Lead sponsor
Guang'anmen Hospital of China Academy of Chinese Medical Sciences (class: other)
Collaborator
Fangshan Hospital of Traditional Chinese Medicine, (class: other)
Collaborator
Peking University First Hospital (class: other)

Record details

Record id
cardio:ct-nct02275468
Content hash
b20158b5603bb1ed1b0341d524d02afd82991827759673df6de75f6d1893803a